-
CytRx Corporation (NASDAQ: CYTR) shares dropped
62.6 percent to $0.940 after the company reported initial results of Phase 3 trial of aldoxorubicin in patients with
second-line soft tissue sarcoma.
-
Escalon Medical Corp. (NASDAQ: ESMC) shares
declined 25.7 percent to $0.751.
-
NF Energy Saving Corp (NASDAQ: NFEC) shares
dropped 16.8 percent to $0.840.
-
VOXX International Corp (NASDAQ: VOXX) shares
fell 7.5 percent to $2.75. VOXX reported a Q1 loss of $0.18 per share on revenue of $155.45 million.
-
DRDGOLD Ltd. (ADR) (NYSE: DRD) shares declined 6
percent to $8.27. JP Morgan downgraded DRDGOLD from Neutral to Underweight.
-
Imperva Inc (NYSE: IMPV) shares dropped 5 percent
to $45.85 in pre-market trading after the company lowered its Q2 guidance. Deutsche Bank downgraded Imperva from Buy to Hold.
-
Fastenal Company (NASDAQ: FAST) shares dropped
3.2 percent to $43.92 as the company reported downbeat Q2 results.
-
Regency Centers Corp (NYSE: REG) shares declined 3
percent to $81.76. Regency Centers priced its 4.35 million share offering for gross proceeds of $353 million.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.